Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-γ-dependent manner

Journal of Hepatology

Volumn 47, Issue 2, 2007, Pages 183-190

  Chen, Yongyan ^a   Sun, Rui ^a   Jiang, Wei ^a   Wei, Haiming ^a   Tian, Zhigang ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Hepatitis B virus; IFN ; Liver injury; Natural killer cell; Polyinosinic:polycytidylic acid

Indexed keywords

AMINOTRANSFERASE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 12; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; KUPFFER CELL; LIVER INJURY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DISEASE SUSCEPTIBILITY; HEPATITIS B SURFACE ANTIGENS; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; KUPFFER CELLS; LIVER; LIVER DISEASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLY I-C; RECEPTORS, INTERFERON;

EID: 34347407333     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.02.020     Document Type: Article

References (53)

1. Seeger C., and Mason W.S. Hepatitis B virus biology. Microbiol Mol Biol Rev 64 (2000) 51-58
2. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
3. Christina M., and Page J.G.R. Immunology of hepatitis B infection. Lancet Infect Dis 2 (2001) 43-50
4. Mackay I.R. Hepatoimmunity: a perspective. Immunol Cell Biol 80 (2002) 36-44
5. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 28 (1998) 84-90
6. Mehal W.Z., Azzaroli F., and Crispe I.N. Immunology of the healthy liver: old questions and new insights. Gastroenterology 120 (2001) 250-260
7. Kita H., Mackay I.R., Van de Water J., and Gershwin M.E. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120 (2001) 1485-1501
8. Chen Y., Wei H., Gao B., Hu Z., Zheng S., and Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an under investigated innate immune response. J Viral Hepat. 1 (2005) 34-38
9. Liu Z.X., Govindarajan S., Okamoto S., and Dennert G. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 164 (2000) 6480-6486
10. Muhlen K.A., Schumann J., Wittke F., Stenger S., Van Rooijen N., Van Kaer L., et al. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol 172 (2004) 3034-3041
11. Abe T., Kawamura H., Kawabe S., Watanabe H., Gejyo F., and Abo T. Liver injury due to sequential activation of natural killer cells and natural killer T cells by carrageenan. J Hepatol 36 (2002) 614-623
12. Ochi M., Ohdan H., Mitsuta H., Onoe T., Tokita D., Hara H., et al. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39 (2004) 1321-1331
13. Dong Z., Wei H., Sun R., Hu Z., Gao B., and Tian Z. Involvement of natural killer cells in Poly(I:C)-induced liver injury. J Hepatol 41 (2004) 966-973
14. Wang J., Sun R., Wei H., Dong Z., and Tian Z. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury. Int Immunopharmacol 6 (2006) 800-807
15. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., and Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97 (2000) 5498-5503
16. Toyabe S., Seki S., Iiai T., Takeda K., Shirai K., Watanabe H., et al. Requirement of IL-4 and liver NK1+T cells for concanavalin A-induced hepatic injury in mice. J Immunol 159 (1997) 1537-1542
17. Nakagawa R., Nagafune I., Tazunoki Y., Ehara H., Tomura H., Iijima R., et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 166 (2001) 6578-6584
18. Kakimi K., Guidotti L.G., Koezuka Y., and Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192 (2000) 921-930
19. Kimura K., Kakimi K., Wieland S., Guidotti L.G., and Chisari F.V. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 169 (2002) 5188-5195
20. Pasquetto V., Guidotti L.G., Kakimi K., Tsuji M., and Chisari F.V. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med 192 (2000) 529-536
21. Sitia G., Iaoqawa M., Kakimi K., Wieland S.F., Chisari F.V., and Guidotti L.G. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc Natl Acad Sci USA 99 (2002) 13717-13722
22. Kakimi K., Lane T.E., Wieland S., Asensio V.C., Campbell I.L., Chisari F.V., et al. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194 (2001) 1755-1766
23. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., and Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
24. Yongyan C., Haiming W., Rui S., and Zhigang T. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers. Int Immunopharmacol 5 (2005) 1839-1852
25. Chisari F.V., Pinkert C.A., Milich D.R., Fillippi P., Mclachlan A., Palmiter R.D., et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 230 (1985) 1157-1160
26. Bigger J.E., Thomas III C.A., and Atherton S.S. NK cell modulation of murine cytomegalovirus retinitis. J Immunol 160 (1998) 5826-5831
27. Fukumura D., Yonei Y., Kurose I., Saito H., Ohishi T., Higuchi H., et al. Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo. Hepatology 24 (1996) 141-149
28. Wei J., Rui S., Haiming W., and Zhigang T. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci USA 102 (2005) 17077-17082
29. Jaruga B., Hong F., Kim W.H., and Gao B. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1044-G1052
30. Trobonjaca Z., Kroger A., Stober D., Leithauser F., Moller P., Hauser H., et al. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J Immunol 168 (2002) 3763-3770
31. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
32. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99 (2002) 8826-8831
33. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 100 (2003) 13483-13488
34. Krmpotic A., Busch D.H., Bubic I., Gebhardt F., Hengel H., Hasan M., et al. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3 (2002) 529-535
35. Lodoen M.B., Abenes G., Umamoto S., Houchins J.P., Liu F., and Lanier L.L. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200 (2004) 1075-1081
36. Krmpotic A., Hasan M., Loewendorf A., Saulig T., Halenius A., Lenac T., et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201 (2005) 211-220
37. Hasan M., Krmpotic A., Ruzsics Z., Bubic I., Lenac T., Halenius A., et al. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 79 (2005) 2920-2930
38. Lenac T., Budt M., Arapovic J., Hasan M., Zimmermann A., Simic H., et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med 203 (2006) 1843-1850
39. Kusters S., Gantner F., Kunstle G., and Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111 (1996) 462-471
40. Tagawa Y., Sekikawa K., and Iwakura Y. Suppression of concanavalin A induced hepatitis in IFN-gamma(-/-) mice, but not in TNFalpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159 (1997) 1418-1428
41. Car B.D., Eng V.M., Schnyder B., Ozmen L., Huang S., Gallay P., et al. Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 179 (1994) 1437-1444
42. Gilles P.N., Guerrette D.L., Ulevitch R.J., Schreiber R.D., and Chisari F.V. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma. Hepatology 16 (1992) 655-663
43. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2 (2005) 92-100
44. Hong F., Jaruga B., Kim W.H., Radaeva S., El-Assal O.N., Tian Z., et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110 (2002) 1503-1513
45. Kim W.H., Hong F., Radaeva S., Jaruga B., Fan S., and Gao B. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury. Am J Physiol Gastrointest Liver Physiol 285 (2003) G761-G768
46. Siebler J., Wirtz S., Klein S., Protschka M., Blessing M., Galle P.R., et al. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation. Hepatology 38 (2003) 1573-1580
47. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179 (1994) 1529-1537
48. Ksontini R., Colagiovanni D.B., Josephs M.D., Edwards III C.K., Tannahill C.L., Solorzano C.C., et al. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol 160 (1998) 4082-4089
49. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J., Brand A., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163 (1999) 57-61
50. Fogler W.E., Volker K., Watanabe M., Wigginton J.M., Roessler P., Brunda M.J., et al. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly downregulated by a mechanism involving T cells and expression of Fas. J Immunol 161 (1998) 6014-6021
51. Nicoletti F., Di Marco R., Zaccone P., Salvaggio A., Magro G., Bendtzen K., et al. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 32 (2000) 728-733
52. Zheng B.J., Ng M.H., He L.F., Yao X., Chan K.W., Yuen K.Y., et al. Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice. Vaccine 19 (2001) 4219-4225
53. Perrillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated disease. Gastroenterology 120 (2000) 1009-1022